"Designing Growth Strategies is in our DNA"

Peptic Ulcer Drugs Market Size, Share & COVID-19 Impact Analysis, By Drugs Type (Proton Pump Inhibitor (PPI), H2 Antagonists, Antibiotics, and Others), By Ulcer Type (Gastric Ulcer and Duodenal Ulcer), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and Regional Forecast, 2020-2027

Last Updated: November 17, 2025 | Format: PDF | Report ID: FBI103483

 


To get information on various segments, share your queries with us

 ATTRIBUTE

 DETAILS

Study Period

  2016-2027

Base Year

  2019

Forecast Period

  2020-2027

Historical Period

  2016-2018

Unit

  Value (USD billion)

Segmentation

Drug Type; Ulcer Type; End User and Geography

By Drug Type

 

  • Proton Pump Inhibitors
  • H2 Antagonists
  • Antibiotics
  • Others

By Ulcer Type

 

  • Gastric Ulcer
  • Duodenal Ulcer

By End User

 

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

By Geography

 

  • North America (USA, Canada)
  • Europe (UK, Germany, France, Italy, Spain, Scandinavia, Rest of Europe)
  • Asia Pacific (Japan, China, India, Australia, Southeast Asia,Rest of Asia Pacific)
  • Latin America (Brazil, Mexico, Rest of Latin America)
  • Middle East & Africa (GCC, South Africa,Rest of MEA)
  • REPORT UPDATE
    IN PROCESS
  • 2019-2032
    (IN PROCESS)
  • 2024
    (IN PROCESS)
Download Free Sample

    man icon
    Mail icon
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann